Category: Company News

EyePoint (NASDAQ:EYPT) reported that its Phase 3 LUGANO trial of DURAVYU in wet age-related macular degeneration did not achieve its primary endpoint in the full dataset, although the company reported positive secondary outcomes and an ad hoc analysis in which DURAVYU was non-inferior to aflibercept. The Phase 3 LUGANO trial result puts added importance on…

NEXGEL (NASDAQ:NXGL) reported second-quarter 2026 revenue of $3.69 million and a net loss of $2.87 million as the healthcare products company worked through a slower-than-expected integration and commercial rollout of its newly formed BioNX Surgical division. The Q2 results highlight a transition period following NEXGEL’s April transaction with Celularity, with supply constraints contributing to a…

argenx (NASDAQ:ARGX) reported positive topline results from its Phase 3 ALKIVIA trial of VYVGART Hytrulo in adults with autoimmune myositis, with the study meeting its primary endpoint in the combined immune-mediated necrotizing myopathy (IMNM) and dermatomyositis (DM) population. The Phase 3 ALKIVIA trial produced a statistically significant 15.4-point treatment advantage over placebo in mean Total…

IM Cannabis (NASDAQ:IMCC) has entered into a definitive agreement to sell IMC Holdings and its European-focused assets to Slil.com Holding, a transaction management expects to improve shareholders’ equity by approximately C$3 million while reducing liabilities and simplifying the company’s structure. The proposed European asset sale would leave IM Cannabis focused on its Israeli medical cannabis…

Glucotrack (NASDAQ:GCTK) has regained compliance with Nasdaq’s stockholders’ equity requirement, with the Nasdaq Hearings Panel granting the company’s request for continued listing subject to certain conditions. The Nasdaq compliance milestone removes one specific listing issue for Glucotrack as management continues its strategic transformation, although the company said it is still working toward full compliance with…

HIVE Digital Technologies (NASDAQ:HIVE) has secured a $350 million AI cloud services agreement through its BUZZ HPC subsidiary, adding about $70 million in annualized revenue under a five-year contract with an investment-grade enterprise customer. The deal increases BUZZ HPC’s total annualized revenue to approximately $180 million and commits HIVE to deploying a new 2,016-GPU AI…

American Fusion has appointed Niclas von Schantz as Strategic Advisor for brand strategy, commercialization and international market development, adding commercial expertise as the company advances engineering and testing of its Texatron Fusion Engine. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion is adding commercialization and international market-development expertise to its Texatron Fusion…

Victory Marine Holdings has appointed Miles Bodie as Director of E-Commerce at its Dunn & Groux Beverage Holdings subsidiary, adding dedicated leadership to expand GUTSI across Amazon, Walmart Marketplace and direct-to-consumer channels. Key Investor Takeaways Why VMHG Stock Is in Focus Victory Marine’s DGBH subsidiary has appointed Bodie to lead the next phase of its…

Netlist has launched new patent infringement proceedings against Micron and other technology companies at the U.S. International Trade Commission, seeking orders that could block allegedly infringing memory products from entering the United States. The company has also filed a separate patent lawsuit against Micron in federal court in California. Key Investor Takeaways Why (USOTC:NLST) Stock…

BioAdaptives has commercially launched XcellaraHeart, opening pre-orders for the flagship product in its seven-formula Xcellara cellular wellness platform, with the first commercial batch scheduled to ship on August 26, 2026. Key Investor Takeaways Why BDPT Stock Is in Focus BioAdaptives has officially launched XcellaraHeart, shifting its Xcellara cellular wellness strategy into the commercial stage. Limited…